AH Equity Partners Bio II Sells 5 M Nautilus Shares: Strategic Rebalance Amid Rising Protein‑Tech Demand
AH Equity Partners Bio II sells 5 million Nautilus shares at $2.35 each— a strategic rebalancing that preserves a 1.8 % stake, while execs buy back shares and the proteomics tech shows growing upside.
3 minutes to read